Total trials
272
Active
45
Phase 3
8
Total enrollment
67,713
Pipeline matrix
Showing 19 of 19 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Metronidazole 0.75% Topical Gel | — | — | — | — | — | 1 | |
| Metronidazole 0.75% Topical Cream | — | — | — | — | — | 1 | |
| Intravenous administered opioid | — | — | — | — | — | 1 | |
| Epidural administered opioid | — | — | — | — | — | 1 | |
| Dostarlimab | — | — | — | — | 2 | ||
| Salsalate Oral | — | — | — | — | 2 | ||
| Doxycycline Hyclate | — | — | — | — | — | 1 | |
| Lutetium Lu 177 dotatate therapy | — | — | — | — | — | 1 | |
| Fish Oil Concentrate, 1000 Mg Oral | — | — | — | — | — | 1 | |
| Psilocybin | — | — | — | — | — | 1 | |
| Ketamine | — | — | — | — | 2 | ||
| Terazosin | — | — | — | — | — | 1 | |
| Terazosine | — | — | — | — | — | 1 | |
| Ascorbate | — | — | — | — | — | 1 | |
| Salsalate 750 MG Oral Tablet [DISALCID] | — | — | — | — | — | 1 | |
| Acetylcholine | — | — | — | — | — | 1 | |
| Thoracolumbar Interfascial Plane (TLIP) Block of bupivacaine | — | — | — | — | — | 1 | |
| IV adenosine | — | — | — | — | — | 1 | |
| IV diltiazem | — | — | — | — | — | 1 |
Next readouts
- 2023-03-01
- 2025-03-18
- 2025-08-12
- 2026-06
- 2026-07-31
- 2026-12-30
- 2026-12-31
- 2026-12-31
- 2027-02-01
- 2027-05-01
Top conditions
- Healthy14
- Knee Osteoarthritis10
- Depression6
- Obesity6
- Hypertension5
- Multiple Sclerosis5
- Cardiovascular Diseases4
- Charcot Marie Tooth Disease3
Frequently asked questions about University of Iowa
- How many clinical trials does University of Iowa have on ClinicalTrials.gov?
- University of Iowa is listed as the lead sponsor on 272 clinical trials in ClinicalTrials.gov, 45 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Iowa's trials are in Phase 3?
- 8 of University of Iowa's trials are in Phase 3, spread across 19 active drug programs.
- What therapeutic areas does University of Iowa focus on?
- University of Iowa's most-studied conditions on ClinicalTrials.gov are Healthy, Knee Osteoarthritis, Depression, Obesity, Hypertension.
- When are University of Iowa's next clinical trial readouts?
- University of Iowa has 10 upcoming primary-completion readouts tracked here; the soonest is “Target Engagement of Terazosin in Healthy Adults”, expected around 2023-03-01.